acetylglucosamine has been researched along with Allergic Encephalomyelitis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Demetriou, M; Dennis, JW; Grigorian, A; Lee, SU; Li, CF; Mortales, CL; Pawling, J | 1 |
Kadomatsu, K; Kitagawa, H; Kusunoki, S; Miyamoto, K; Moriguchi, K; Tanaka, N; Ueno, R | 1 |
Araujo, L; Choudhury, B; Demetriou, M; Grigorian, A; Naidu, NN; Place, DJ | 1 |
3 other study(ies) available for acetylglucosamine and Allergic Encephalomyelitis
Article | Year |
---|---|
Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (TH1)/TH17 responses and autoimmunity.
Topics: Acetylation; Acetylglucosamine; Animals; Cell Differentiation; Cell Proliferation; Encephalomyelitis, Autoimmune, Experimental; Humans; Mice; Multiple Sclerosis; Permeability; Th1 Cells; Th17 Cells | 2019 |
Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis.
Topics: Acetylglucosamine; Animals; Carbohydrate Sulfotransferases; Chondroitin Sulfates; Encephalomyelitis, Autoimmune, Experimental; Gene Expression Regulation, Enzymologic; Mice; Mice, Knockout; Multiple Sclerosis; Sulfotransferases; T-Lymphocytes | 2014 |
N-acetylglucosamine inhibits T-helper 1 (Th1)/T-helper 17 (Th17) cell responses and treats experimental autoimmune encephalomyelitis.
Topics: Acetylglucosamine; Animals; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Mice; Mice, Transgenic; Multiple Sclerosis; Th1 Cells; Th17 Cells; Time Factors | 2011 |